Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$4.24 - $11.12 $1,382 - $3,625
-326 Reduced 3.27%
9,644 $54,000
Q4 2022

Feb 13, 2023

SELL
$9.86 - $23.83 $225,231 - $544,348
-22,843 Reduced 69.62%
9,970 $100,000
Q3 2022

Nov 08, 2022

SELL
$21.04 - $36.06 $15,695 - $26,900
-746 Reduced 2.22%
32,813 $735,000
Q2 2022

Aug 08, 2022

SELL
$17.78 - $42.39 $109,933 - $262,097
-6,183 Reduced 15.56%
33,559 $832,000
Q1 2022

May 17, 2022

SELL
$29.67 - $60.28 $98,029 - $199,165
-3,304 Reduced 7.68%
39,742 $1.54 Million
Q4 2021

Feb 15, 2022

BUY
$47.84 - $64.34 $80,275 - $107,962
1,678 Added 4.06%
43,046 $2.52 Million
Q3 2021

Nov 12, 2021

BUY
$59.27 - $95.73 $349,811 - $564,998
5,902 Added 16.64%
41,368 $2.45 Million
Q2 2021

Jul 30, 2021

BUY
$67.25 - $92.52 $389,781 - $536,245
5,796 Added 19.53%
35,466 $3.08 Million
Q1 2021

May 07, 2021

BUY
$72.16 - $117.4 $875,156 - $1.42 Million
12,128 Added 69.14%
29,670 $2.45 Million
Q4 2020

Feb 12, 2021

BUY
$38.09 - $100.95 $423,141 - $1.12 Million
11,109 Added 172.69%
17,542 $1.6 Million
Q3 2020

Nov 16, 2020

BUY
$30.41 - $40.5 $90,621 - $120,690
2,980 Added 86.3%
6,433 $257,000
Q2 2020

Aug 12, 2020

BUY
$20.21 - $35.23 $69,785 - $121,649
3,453 New
3,453 $118,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $222M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.